We previously developed the human cell-line activation test (h-CLAT) in vitro skin sensitisation test, based on our reported finding that a 24-hour exposure of THP-1 cells (a human monocytic leukaemia cell line) to sensitisers is sufficient to induce the augmented expression of CD86 and CD54. The aim of this study is to confirm the predictive value of h-CLAT for skin sensitisation activity by employing a larger number of test chemicals. One hundred chemicals were selected, according to their categorisation in the local lymph node assay (LLNA), as being: extreme, strong, moderate and weak sensitisers, and non-sensitisers. The correlation of the h-CLAT results with the LLNA results was 84%. There were some false negatives (e.g. benzoyl peroxide, hexyl cinnamic aldehyde) and some false positives (e.g. 1-bromobutane, diethylphthalate). Eight out of the 9 false negatives (89%) were water-insoluble chemicals. The h-CLAT could positively predict not only extreme and strong sensitisers, but also moderate and weak sensitisers, though the detection rates of weak sensitisers and non-sensitisers were comparatively low. Some sensitisers enhanced both CD86 and CD54 levels, and some enhanced the level of only one of them. The use of the combination of CD86 and CD54 induction as a positive indicator, improved the accuracy of the test. In conclusion, the h-CLAT is expected to be a useful cell-based in vitro method for predicting skin sensitisation potential.
De SilvaO., BasketterD.A., BarrattM.D., CorsiniE., CroninM.T.D., DasP.K., DegwertJ., EnkA., GarrigueJ-L., HauserC., KimberI., LepoittevinJ-P., PeguetJ. & PonecM. (1996). Alternative methods for skin sensitisation testing. ATLA24, 683–705.
2.
AibaS., TerunumaA., ManomeH. & TagamiH. (1997). Dendritic cells differently respond to haptens and irritants by their production of cytokines and expression of co-stimulatory molecules. European Journal of Immunology27, 3031–3038.
3.
HopperU., DegwertJ. & SteckelF. (1995). Use of CD1a- dendritic cells and keratinocytes to characterize cellular reaction involved in allergic contact dermatitis. Journal of Cellular Biochemistry59, Suppl. S21A, 11–18.
4.
RougierN., RedziniakG., MouginD., SchmittD. & VincentC. (2000). In vitro evaluation of the sensitization potential of weak contact allergens using Langerhans-like dendritic cells and autologous T cells. Toxicology145, 73–82.
5.
AshikagaT., HoyaM., ItagakiH., KatumuraY. & AibaS. (2002). Evaluation of CD86 expression in THP-1 human monocyte cells as predictive endpoints for contact sensitizers. Toxicology in Vitro16, 711–716.
6.
YoshidaY., SakaguchiH., ItoY., OkudaM. & SuzukiH. (2003). Evaluation of the skin sensitization potential of chemicals using expression of co-stimulatory molecules. Toxicology in Vitro17, 221–218.
7.
AshikagaT., YoshidaY., HirotaM., YoneyamaK., ItagakiH., SakaguchiH., MiyazawaY., ItoY., SuzukiH. & ToyodaH. (2006). Development of an in vitro skin sensitization test using human cell lines: Human Cell Line Activation Test (h-CLAT). I. Optimization of the h-CLAT protocol. Toxicology in Vitro20, 767–773.
8.
SakaguchiH., AshikagaT., MiyazawaY., YoshidaY., ItoY., YoneyamaK., HirotaM., ItagakiH., ToyodaH. & SuzukiH. (2006). Development of an in vitro skin sensitization test using human cell lines: Human Cell Line Activation Test (h-CLAT). II. An inter-laboratory study of the h-CLAT. Toxicology in Vitro20, 774–784.
9.
SakaguchiH., MiyazawaM., YoshidaY., ItoY. & SuzukiH. (2007). Prediction of preservative sensitization potential using surface marker CD86 and/or CD54 expression on human cell line, THP-1. Archives of Dermatological Research298, 427–437.
10.
BocchiettoE., PaolucciC., BredaD., SabbioniE. & BurasteroS.E. (2007). Human monocytoid THP-1 cell line versus monocyte-derived human immature dendritic cells as in vitro models for predicting the sensitising potential of chemicals. International Journal of Immunopathology & Pharmacology20, 259–265.
11.
AshikagaT., SakaguchiH., OkamotoK., MizunoM., SatoJ., YamadaT., YoshidaM., OtaN., HasegawaS., KodamaT., OkamotoY., KuwaharaH., KosakaN., SonoS. & OhnoY. (2008). Assessment of the human Cell Line Activation Test (h-CLAT) for skin sensitization: Results of the first Japanese inter-laboratory study. AATEX13, 27–35.
12.
BeckerD., KuhnU., LempertzU., EnkA., SalogaJ. & KnopJ. (1997). Flow-cytometric screening for the modulation of receptor-mediated endocytosis in human dendritic cells: Implications for the development of an in vitro technique for predictive testing of contact sensitizers. Journal of Immunological Methods203, 171–180.
13.
GerberickG.F., RyanC.A., KernP.S., SchlatterH., DearmanR.J., KimberI. & PatlewiczG.Y. (2005). Compilation of historical local lymph node data for evaluation of skin sensitization alternative methods. Cell Biology & Toxicology97, 417–427.
14.
CasatiS., AebyP., KimberI., MaxwellG., OvigneJ-M., RoggenE., RovidaC., TostiL. & BasketterD. (2009). Selection of chemicals for development and evaluation of in vitro methods for skin sensitisation testing. ATLA37, 305–312.
SakaguchiH., AshikagaT., MasaakiM., KosakaN., ItoY., YoneyamaK., SonoS., ItagakiH., ToyodaH. & SuzukiH. (2009). The relationship between CD86/CD54 expression and THP-1 cell viability in an in vitro skin sensitization test — human Cell Line Activation Test (h-CLAT). Cell Biology & Toxicology25, 109–126.
17.
GerberickG.F., VassalloJ.D., FoertschL.M., PriceB.B., ChaneyJ.G. & LepoittevinJ.P. (2006). Quantification of chemical peptide reactivity for screening contact allergens: A classification tree model approach. Toxicological Sciences97, 417–427.
18.
BossJ.D. & MeinardM.M. (2000). The 500 Dalton rule for skin penetration of chemical compounds and drugs. Experimental Dermatology9, 165–169.
19.
SmithC.K. & HotchkissS.A. (2001). Appendix I: In vivo sensitisation data and physico-chemical properties of xenobiotics. In Allergic Contact Dermatitis: Chemical and Metabolic Mechanisms, pp. 229–236. London, UK: Taylor & Francis.
20.
MiyazawaM., ItoY., KosakaN., SakaguchiH. & SuzukiH. (2008). Role of MAPK signaling pathway in the activation of dendritic type cell line, THP-1, induced by DNCB and NiSO4. The Journal of Toxicological Sciences33, 51–59.
21.
PythonF., GoebelC. & AebyO. (2007). Assessment of the U-937 cell line for the detection of contact allergens. Toxicology & Applied Pharmacology220, 112–124.
22.
NakayamaK., NittoT., InoueT. & NodeK. (2008). Expression of the cytochrome P450 epoxygenase CYP2J2 in human monocytic leukocytes. Life Sciences29, 339–345.
23.
SmithC.K. & HotchkissS.A. (2001). Xenobiotics as skin sensitizers: Metabolic activation and detoxication, and protein-binding mechanisms. In Allergic Contact Dermatitis: Chemical and Metabolic Mechanisms, pp. 119–205. London, UK: Taylor & Francis.
24.
NachtS., YeungD., BeasleyJ.N.Jr, AnjoM.D. & MaibachH.I. (1981). Benzoyl peroxide: Percutaneous penetration and metabolic disposition. Journal of the American Academy of Dermatology4, 31–37.
25.
BasketterD.A., BremmerJ.N., BuckleyP., KammullerM.E., KawabataT., KimberI., LovelessS.E., MagdaS., StringerD.A. & VohrH.W. (1995). Pathology considerations for, and subsequent risk assessment of, chemicals identified as immunosuppressive in routine toxicology. Food & Chemical Toxicology33, 1051–1056.
26.
RobertsD.W., PatlewiczG., KernP.S., GerberickF., KimberI., DearmanR.J., RyanC.A., BasketterD.A. & AptulaA.O. (2007). Mechanistic applicability domain classification of a local lymph node assay dataset for skin sensitization. Chemical Research Toxicology20, 1019–1030.
